Blume Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3K | Buy |
44
+14
| +47% | +$10.9K | 0.01% | 203 |
|
|
2025
Q1 | $24.8K | Buy |
30
+5
| +20% | +$4.13K | 0.01% | 217 |
|
|
2024
Q4 | $19.3K | Sell |
25
-15
| -38% | -$11.6K | ﹤0.01% | 227 |
|
|
2024
Q3 | $35.4K | Buy |
40
+15
| +60% | +$13.3K | 0.01% | 207 |
|
|
2024
Q2 | $22.6K | Hold |
25
| – | – | 0.01% | 217 |
|
|
2024
Q1 | $19.4K | Hold |
25
| – | – | ﹤0.01% | 220 |
|
|
2023
Q4 | $14.6K | Hold |
25
| – | – | ﹤0.01% | 230 |
|
|
2023
Q3 | $13.4K | Sell |
25
-9
| -26% | -$4.83K | ﹤0.01% | 233 |
|
|
2023
Q2 | $15.9K | Hold |
34
| – | – | ﹤0.01% | 223 |
|
|
2023
Q1 | $11.7K | Hold |
34
| – | – | ﹤0.01% | 236 |
|
|
2022
Q4 | $12.4K | Hold |
34
| – | – | ﹤0.01% | 238 |
|
|
2022
Q3 | $11K | Buy |
+34
| New | +$11K | ﹤0.01% | 237 |
|